RxDoctor Payments Data

Caleb Savage, NP

Nurse Practitioner · Cookeville, TNNPI 1487350567

Payments from drug & device makers

$1,463in general payments, 2019–2025

Across 65 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$805
  • Johnson & Johnson$309
  • Boston Scientific$115
  • Amgen$83
  • Abiomed$46
  • Pfizer$43
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$1,463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,463 in reported general payments places this provider in the 75th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,028
Medicare patients
348
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban121$123,574
Inderal LaPropranolol Hcl11$19,585
Dofetilide98$17,156
XareltoRivaroxaban11$14,312
Flecainide Acetate41$1,701
Propafenone Hcl31$1,307
Diltiazem 24hr Er (Cd)Diltiazem Hcl54$1,285
Metoprolol Succinate65$1,208
Diltiazem Hcl28$1,131
Amiodarone Hcl63$1,059
SotalolSotalol Hcl47$958
Metoprolol Tartrate87$588
ClopidogrelClopidogrel Bisulfate45$406
Propranolol Hcl24$310
Lisinopril29$134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$43$123,574121 claims
Johnson & JohnsonXarelto$309$14,31211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Cookeville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →